Biovance Capital

Biovance Capital

Biovance Capital

Activities

  • Public European

Description

We support biotech companies across Europe developing new therapeutics.
Biovance Capital Fund I is a biotech fund up to € 60M supported by the European Investment Fund, Caixa Capital, and others. The fund will invest in early-stage biotech companies across Europe and plans to start activities by the end of 2023.

Referent Contact

Ricardo Henriques

Co-Founder and Managing Partner
rhenriques@biovancecapital.com

Biovance Capital

Address

Estrada do Paço do Lumiar Campus do Lumiar, Edifício R
1649-038 Lisboa, Tejo, Portugal

Contact

rhenriques@bionovacapital.com

Description

We support biotech companies across Europe developing new therapeutics.
Biovance Capital Fund I is a biotech fund up to € 60M supported by the European Investment Fund, Caixa Capital, and others. The fund will invest in early-stage biotech companies across Europe and plans to start activities by the end of 2023.

Matchmaking

Connect with Biovance Capital

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

Partnership needs

  • Business Development

TRL